home All News open_in_new Full Article

Los fármacos antiobesidad Ozempic, Mounjaro o Wegoby pueden aumentar el riesgo de embarazo no deseado

La agencia reguladora de medicamentos y productos sanitarios del Reino Unido (MHRA, en sus siglas inglesas) ha publicado una advertencia sobre el aumento del riesgo de embarazos no deseados en mujeres que se administran medicamentos agonistas del receptor GLP-1, conocidos por sus marcas comerciales Ozempic, Mounjaro, Wegovy, Saxenda y Victoza como terapia para la diabetes o la obesidad. Leer


today 16 h. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 1566326396
Add Watch Country

arrow_drop_down